nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ABCB1—kidney cancer	0.288	1	CbGaD
Lisinopril—ABCB1—Temsirolimus—kidney cancer	0.0683	0.225	CbGbCtD
Lisinopril—ABCB1—Pazopanib—kidney cancer	0.0359	0.118	CbGbCtD
Lisinopril—ABCB1—Dactinomycin—kidney cancer	0.0328	0.108	CbGbCtD
Lisinopril—ABCB1—Gemcitabine—kidney cancer	0.0259	0.0856	CbGbCtD
Lisinopril—ABCB1—Erlotinib—kidney cancer	0.0256	0.0845	CbGbCtD
Lisinopril—ACE2—nephron—kidney cancer	0.0238	0.226	CbGeAlD
Lisinopril—ABCB1—Paclitaxel—kidney cancer	0.0234	0.0773	CbGbCtD
Lisinopril—ACE—renal artery—kidney cancer	0.0223	0.212	CbGeAlD
Lisinopril—ABCB1—Sorafenib—kidney cancer	0.0208	0.0687	CbGbCtD
Lisinopril—ABCB1—Vinblastine—kidney cancer	0.0205	0.0678	CbGbCtD
Lisinopril—ABCB1—Vincristine—kidney cancer	0.0202	0.0667	CbGbCtD
Lisinopril—ABCB1—Sunitinib—kidney cancer	0.0169	0.0557	CbGbCtD
Lisinopril—ABCB1—Doxorubicin—kidney cancer	0.0126	0.0417	CbGbCtD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—MME—kidney cancer	0.00784	0.159	CbGpPWpGaD
Lisinopril—ACE—nephron—kidney cancer	0.0078	0.074	CbGeAlD
Lisinopril—ACE—urine—kidney cancer	0.00625	0.0593	CbGeAlD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—CTSD—kidney cancer	0.00569	0.115	CbGpPWpGaD
Lisinopril—ACE2—nephron tubule—kidney cancer	0.00515	0.0488	CbGeAlD
Lisinopril—ACE2—renal system—kidney cancer	0.00468	0.0444	CbGeAlD
Lisinopril—ACE2—kidney—kidney cancer	0.00452	0.0429	CbGeAlD
Lisinopril—ACE2—cortex of kidney—kidney cancer	0.00441	0.0418	CbGeAlD
Lisinopril—ACE2—gonad—kidney cancer	0.0042	0.0398	CbGeAlD
Lisinopril—ACE2—cardiac atrium—kidney cancer	0.00419	0.0398	CbGeAlD
Lisinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—kidney cancer	0.0035	0.071	CbGpPWpGaD
Lisinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSD—kidney cancer	0.00254	0.0515	CbGpPWpGaD
Lisinopril—SLC15A1—nephron tubule—kidney cancer	0.00235	0.0223	CbGeAlD
Lisinopril—SLC15A1—renal system—kidney cancer	0.00213	0.0202	CbGeAlD
Lisinopril—SLC15A1—kidney—kidney cancer	0.00206	0.0196	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—MME—kidney cancer	0.00206	0.0418	CbGpPWpGaD
Lisinopril—ACE—nephron tubule—kidney cancer	0.00168	0.016	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—ACHE—kidney cancer	0.00158	0.032	CbGpPWpGaD
Lisinopril—ACE—renal system—kidney cancer	0.00153	0.0145	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—PAX6—kidney cancer	0.0015	0.0305	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—CTSD—kidney cancer	0.0015	0.0303	CbGpPWpGaD
Lisinopril—ACE—kidney—kidney cancer	0.00148	0.014	CbGeAlD
Lisinopril—ACE—cortex of kidney—kidney cancer	0.00144	0.0137	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—BCHE—kidney cancer	0.00138	0.0279	CbGpPWpGaD
Lisinopril—ACE—gonad—kidney cancer	0.00137	0.013	CbGeAlD
Lisinopril—ACE—cardiac atrium—kidney cancer	0.00137	0.013	CbGeAlD
Lisinopril—ACE—Peptide hormone metabolism—MME—kidney cancer	0.000921	0.0187	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—EIF5B—kidney cancer	0.000788	0.016	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—POMC—kidney cancer	0.000712	0.0144	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—ACHE—kidney cancer	0.000706	0.0143	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CUL7—kidney cancer	0.000703	0.0142	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—PAX6—kidney cancer	0.000672	0.0136	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—HSPA9—kidney cancer	0.00067	0.0136	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—CTSD—kidney cancer	0.000668	0.0135	CbGpPWpGaD
Lisinopril—Ramipril—BCHE—kidney cancer	0.000638	0.472	CrCbGaD
Lisinopril—ACE—Peptide hormone metabolism—BCHE—kidney cancer	0.000615	0.0125	CbGpPWpGaD
Lisinopril—ABCB1—nephron tubule—kidney cancer	0.000592	0.00562	CbGeAlD
Lisinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.000547	0.0111	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MUC4—kidney cancer	0.000546	0.0111	CbGpPWpGaD
Lisinopril—ABCB1—renal system—kidney cancer	0.000539	0.00511	CbGeAlD
Lisinopril—ABCB1—kidney—kidney cancer	0.000521	0.00494	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—ST3GAL2—kidney cancer	0.00052	0.0105	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—CTNNB1—kidney cancer	0.000508	0.0103	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—EEF2—kidney cancer	0.000508	0.0103	CbGpPWpGaD
Lisinopril—ABCB1—cortex of kidney—kidney cancer	0.000507	0.00481	CbGeAlD
Lisinopril—ABCB1—gonad—kidney cancer	0.000483	0.00458	CbGeAlD
Lisinopril—ABCB1—Allograft Rejection—HARS—kidney cancer	0.000455	0.00923	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MME—kidney cancer	0.000389	0.00789	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—RPL14—kidney cancer	0.000362	0.00733	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—HSPD1—kidney cancer	0.000362	0.00733	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—EIF5B—kidney cancer	0.000352	0.00713	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.000322	0.00652	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—POMC—kidney cancer	0.000318	0.00644	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CUL7—kidney cancer	0.000314	0.00636	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—HSPA9—kidney cancer	0.000299	0.00607	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ACHE—kidney cancer	0.000298	0.00605	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—EIF4EBP1—kidney cancer	0.000295	0.00598	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—PAX6—kidney cancer	0.000284	0.00576	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CTSD—kidney cancer	0.000283	0.00573	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—PGK1—kidney cancer	0.000276	0.0056	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000273	0.00553	CbGpPWpGaD
Lisinopril—Nateglinide—PTGS1—kidney cancer	0.000266	0.197	CrCbGaD
Lisinopril—ABCB1—Allograft Rejection—LRRK2—kidney cancer	0.000262	0.0053	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—BCHE—kidney cancer	0.00026	0.00527	CbGpPWpGaD
Lisinopril—Cilazapril—ABCB1—kidney cancer	0.000258	0.191	CrCbGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NDRG1—kidney cancer	0.000257	0.0052	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MUC4—kidney cancer	0.000244	0.00495	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000241	0.00489	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—CA9—kidney cancer	0.000235	0.00476	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ST3GAL2—kidney cancer	0.000232	0.0047	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—CTNNB1—kidney cancer	0.000227	0.0046	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—EEF2—kidney cancer	0.000227	0.0046	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—IGF2—kidney cancer	0.000201	0.00408	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	0.000191	0.00387	CbGpPWpGaD
Lisinopril—Enalapril—ABCB1—kidney cancer	0.00019	0.14	CrCbGaD
Lisinopril—ACE—Metabolism of proteins—MME—kidney cancer	0.000174	0.00352	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPL14—kidney cancer	0.000162	0.00328	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—HSPD1—kidney cancer	0.000162	0.00328	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL13—kidney cancer	0.000149	0.00303	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000144	0.00292	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	0.000141	0.00285	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000139	0.00282	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000139	0.00281	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000139	0.00281	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000139	0.00281	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—POMC—kidney cancer	0.000134	0.00272	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ACHE—kidney cancer	0.000133	0.0027	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—EIF4EBP1—kidney cancer	0.000132	0.00267	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PAX6—kidney cancer	0.000127	0.00257	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CTSD—kidney cancer	0.000126	0.00256	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—BCHE—kidney cancer	0.000116	0.00235	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	0.000102	0.00206	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CTNNB1—kidney cancer	9.59e-05	0.00194	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	9.09e-05	0.00184	CbGpPWpGaD
Lisinopril—Nausea—Erlotinib—kidney cancer	9.07e-05	0.000358	CcSEcCtD
Lisinopril—Alopecia—Capecitabine—kidney cancer	9.07e-05	0.000358	CcSEcCtD
Lisinopril—Dry mouth—Paclitaxel—kidney cancer	9.06e-05	0.000358	CcSEcCtD
Lisinopril—Diarrhoea—Sunitinib—kidney cancer	9.05e-05	0.000357	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—IGF2—kidney cancer	8.99e-05	0.00182	CbGpPWpGaD
Lisinopril—Ataxia—Doxorubicin—kidney cancer	8.99e-05	0.000355	CcSEcCtD
Lisinopril—Mental disorder—Capecitabine—kidney cancer	8.99e-05	0.000355	CcSEcCtD
Lisinopril—Asthenia—Dactinomycin—kidney cancer	8.98e-05	0.000355	CcSEcCtD
Lisinopril—Confusional state—Paclitaxel—kidney cancer	8.96e-05	0.000354	CcSEcCtD
Lisinopril—Blood creatinine increased—Doxorubicin—kidney cancer	8.96e-05	0.000354	CcSEcCtD
Lisinopril—Erythema—Capecitabine—kidney cancer	8.93e-05	0.000353	CcSEcCtD
Lisinopril—Malnutrition—Capecitabine—kidney cancer	8.93e-05	0.000353	CcSEcCtD
Lisinopril—Dehydration—Doxorubicin—kidney cancer	8.89e-05	0.000351	CcSEcCtD
Lisinopril—Oedema—Paclitaxel—kidney cancer	8.88e-05	0.000351	CcSEcCtD
Lisinopril—Anaphylactic shock—Paclitaxel—kidney cancer	8.88e-05	0.000351	CcSEcCtD
Lisinopril—Abdominal pain—Vincristine—kidney cancer	8.84e-05	0.000349	CcSEcCtD
Lisinopril—Body temperature increased—Vincristine—kidney cancer	8.84e-05	0.000349	CcSEcCtD
Lisinopril—Infection—Paclitaxel—kidney cancer	8.82e-05	0.000348	CcSEcCtD
Lisinopril—Flatulence—Capecitabine—kidney cancer	8.8e-05	0.000347	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	8.77e-05	0.00178	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	8.77e-05	0.00178	CbGpPWpGaD
Lisinopril—Dysgeusia—Capecitabine—kidney cancer	8.75e-05	0.000345	CcSEcCtD
Lisinopril—Dizziness—Sunitinib—kidney cancer	8.74e-05	0.000345	CcSEcCtD
Lisinopril—Feeling abnormal—Gemcitabine—kidney cancer	8.74e-05	0.000345	CcSEcCtD
Lisinopril—Shock—Paclitaxel—kidney cancer	8.74e-05	0.000345	CcSEcCtD
Lisinopril—Vomiting—Sorafenib—kidney cancer	8.74e-05	0.000345	CcSEcCtD
Lisinopril—Orthostatic hypotension—Doxorubicin—kidney cancer	8.73e-05	0.000345	CcSEcCtD
Lisinopril—Thrombocytopenia—Paclitaxel—kidney cancer	8.7e-05	0.000343	CcSEcCtD
Lisinopril—Tachycardia—Paclitaxel—kidney cancer	8.67e-05	0.000342	CcSEcCtD
Lisinopril—Rash—Sorafenib—kidney cancer	8.66e-05	0.000342	CcSEcCtD
Lisinopril—Dermatitis—Sorafenib—kidney cancer	8.65e-05	0.000342	CcSEcCtD
Lisinopril—Back pain—Capecitabine—kidney cancer	8.64e-05	0.000341	CcSEcCtD
Lisinopril—Breast disorder—Doxorubicin—kidney cancer	8.64e-05	0.000341	CcSEcCtD
Lisinopril—Skin disorder—Paclitaxel—kidney cancer	8.63e-05	0.000341	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	8.61e-05	0.00034	CcSEcCtD
Lisinopril—Headache—Sorafenib—kidney cancer	8.61e-05	0.00034	CcSEcCtD
Lisinopril—Muscle spasms—Capecitabine—kidney cancer	8.59e-05	0.000339	CcSEcCtD
Lisinopril—Hyperhidrosis—Paclitaxel—kidney cancer	8.59e-05	0.000339	CcSEcCtD
Lisinopril—Diarrhoea—Dactinomycin—kidney cancer	8.56e-05	0.000338	CcSEcCtD
Lisinopril—Nasopharyngitis—Doxorubicin—kidney cancer	8.55e-05	0.000337	CcSEcCtD
Lisinopril—Anorexia—Paclitaxel—kidney cancer	8.47e-05	0.000334	CcSEcCtD
Lisinopril—Gastritis—Doxorubicin—kidney cancer	8.46e-05	0.000334	CcSEcCtD
Lisinopril—Vision blurred—Capecitabine—kidney cancer	8.42e-05	0.000332	CcSEcCtD
Lisinopril—Vomiting—Sunitinib—kidney cancer	8.41e-05	0.000332	CcSEcCtD
Lisinopril—Body temperature increased—Gemcitabine—kidney cancer	8.39e-05	0.000331	CcSEcCtD
Lisinopril—Tremor—Capecitabine—kidney cancer	8.37e-05	0.00033	CcSEcCtD
Lisinopril—Rash—Sunitinib—kidney cancer	8.34e-05	0.000329	CcSEcCtD
Lisinopril—Dermatitis—Sunitinib—kidney cancer	8.33e-05	0.000329	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	8.32e-05	0.00169	CbGpPWpGaD
Lisinopril—Hypotension—Paclitaxel—kidney cancer	8.3e-05	0.000328	CcSEcCtD
Lisinopril—Ill-defined disorder—Capecitabine—kidney cancer	8.29e-05	0.000327	CcSEcCtD
Lisinopril—Headache—Sunitinib—kidney cancer	8.28e-05	0.000327	CcSEcCtD
Lisinopril—Asthma—Doxorubicin—kidney cancer	8.26e-05	0.000326	CcSEcCtD
Lisinopril—Influenza—Doxorubicin—kidney cancer	8.26e-05	0.000326	CcSEcCtD
Lisinopril—Anaemia—Capecitabine—kidney cancer	8.25e-05	0.000326	CcSEcCtD
Lisinopril—Hypersensitivity—Vincristine—kidney cancer	8.24e-05	0.000325	CcSEcCtD
Lisinopril—Eosinophilia—Doxorubicin—kidney cancer	8.18e-05	0.000323	CcSEcCtD
Lisinopril—Nausea—Sorafenib—kidney cancer	8.16e-05	0.000322	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	8.16e-05	0.00165	CbGpPWpGaD
Lisinopril—Pancreatitis—Doxorubicin—kidney cancer	8.1e-05	0.00032	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Paclitaxel—kidney cancer	8.09e-05	0.000319	CcSEcCtD
Lisinopril—Malaise—Capecitabine—kidney cancer	8.05e-05	0.000318	CcSEcCtD
Lisinopril—Angina pectoris—Doxorubicin—kidney cancer	8.05e-05	0.000318	CcSEcCtD
Lisinopril—Insomnia—Paclitaxel—kidney cancer	8.03e-05	0.000317	CcSEcCtD
Lisinopril—Vertigo—Capecitabine—kidney cancer	8.02e-05	0.000317	CcSEcCtD
Lisinopril—Asthenia—Vincristine—kidney cancer	8.02e-05	0.000317	CcSEcCtD
Lisinopril—Syncope—Capecitabine—kidney cancer	8.01e-05	0.000316	CcSEcCtD
Lisinopril—Leukopenia—Capecitabine—kidney cancer	7.99e-05	0.000316	CcSEcCtD
Lisinopril—Paraesthesia—Paclitaxel—kidney cancer	7.98e-05	0.000315	CcSEcCtD
Lisinopril—Vomiting—Dactinomycin—kidney cancer	7.96e-05	0.000314	CcSEcCtD
Lisinopril—Bronchitis—Doxorubicin—kidney cancer	7.95e-05	0.000314	CcSEcCtD
Lisinopril—Dyspnoea—Paclitaxel—kidney cancer	7.92e-05	0.000313	CcSEcCtD
Lisinopril—Somnolence—Paclitaxel—kidney cancer	7.9e-05	0.000312	CcSEcCtD
Lisinopril—Palpitations—Capecitabine—kidney cancer	7.89e-05	0.000312	CcSEcCtD
Lisinopril—Rash—Dactinomycin—kidney cancer	7.89e-05	0.000312	CcSEcCtD
Lisinopril—Nausea—Sunitinib—kidney cancer	7.85e-05	0.00031	CcSEcCtD
Lisinopril—Loss of consciousness—Capecitabine—kidney cancer	7.85e-05	0.00031	CcSEcCtD
Lisinopril—Pancytopenia—Doxorubicin—kidney cancer	7.85e-05	0.00031	CcSEcCtD
Lisinopril—Dyspepsia—Paclitaxel—kidney cancer	7.82e-05	0.000309	CcSEcCtD
Lisinopril—Cough—Capecitabine—kidney cancer	7.79e-05	0.000308	CcSEcCtD
Lisinopril—Dysuria—Doxorubicin—kidney cancer	7.73e-05	0.000305	CcSEcCtD
Lisinopril—Neutropenia—Doxorubicin—kidney cancer	7.73e-05	0.000305	CcSEcCtD
Lisinopril—Decreased appetite—Paclitaxel—kidney cancer	7.72e-05	0.000305	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Doxorubicin—kidney cancer	7.68e-05	0.000303	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Paclitaxel—kidney cancer	7.67e-05	0.000303	CcSEcCtD
Lisinopril—Fatigue—Paclitaxel—kidney cancer	7.66e-05	0.000302	CcSEcCtD
Lisinopril—Diarrhoea—Vincristine—kidney cancer	7.65e-05	0.000302	CcSEcCtD
Lisinopril—Asthenia—Gemcitabine—kidney cancer	7.61e-05	0.0003	CcSEcCtD
Lisinopril—Chest pain—Capecitabine—kidney cancer	7.6e-05	0.0003	CcSEcCtD
Lisinopril—Arthralgia—Capecitabine—kidney cancer	7.6e-05	0.0003	CcSEcCtD
Lisinopril—Myalgia—Capecitabine—kidney cancer	7.6e-05	0.0003	CcSEcCtD
Lisinopril—Constipation—Paclitaxel—kidney cancer	7.6e-05	0.0003	CcSEcCtD
Lisinopril—Pain—Paclitaxel—kidney cancer	7.6e-05	0.0003	CcSEcCtD
Lisinopril—Anxiety—Capecitabine—kidney cancer	7.58e-05	0.000299	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	7.55e-05	0.000298	CcSEcCtD
Lisinopril—Photosensitivity reaction—Doxorubicin—kidney cancer	7.54e-05	0.000298	CcSEcCtD
Lisinopril—Weight increased—Doxorubicin—kidney cancer	7.52e-05	0.000297	CcSEcCtD
Lisinopril—Discomfort—Capecitabine—kidney cancer	7.51e-05	0.000297	CcSEcCtD
Lisinopril—Pruritus—Gemcitabine—kidney cancer	7.51e-05	0.000296	CcSEcCtD
Lisinopril—Weight decreased—Doxorubicin—kidney cancer	7.47e-05	0.000295	CcSEcCtD
Lisinopril—Hyperglycaemia—Doxorubicin—kidney cancer	7.45e-05	0.000294	CcSEcCtD
Lisinopril—Dry mouth—Capecitabine—kidney cancer	7.44e-05	0.000294	CcSEcCtD
Lisinopril—Nausea—Dactinomycin—kidney cancer	7.43e-05	0.000293	CcSEcCtD
Lisinopril—Pneumonia—Doxorubicin—kidney cancer	7.41e-05	0.000293	CcSEcCtD
Lisinopril—Dizziness—Vincristine—kidney cancer	7.39e-05	0.000292	CcSEcCtD
Lisinopril—Confusional state—Capecitabine—kidney cancer	7.35e-05	0.00029	CcSEcCtD
Lisinopril—Feeling abnormal—Paclitaxel—kidney cancer	7.32e-05	0.000289	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.31e-05	0.00148	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	7.31e-05	0.00148	CbGpPWpGaD
Lisinopril—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	7.3e-05	0.000288	CcSEcCtD
Lisinopril—Oedema—Capecitabine—kidney cancer	7.29e-05	0.000288	CcSEcCtD
Lisinopril—Gastrointestinal pain—Paclitaxel—kidney cancer	7.26e-05	0.000287	CcSEcCtD
Lisinopril—Diarrhoea—Gemcitabine—kidney cancer	7.26e-05	0.000287	CcSEcCtD
Lisinopril—Renal failure—Doxorubicin—kidney cancer	7.24e-05	0.000286	CcSEcCtD
Lisinopril—Infection—Capecitabine—kidney cancer	7.24e-05	0.000286	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	7.24e-05	0.00147	CbGpPWpGaD
Lisinopril—Neuropathy peripheral—Doxorubicin—kidney cancer	7.22e-05	0.000285	CcSEcCtD
Lisinopril—Jaundice—Doxorubicin—kidney cancer	7.18e-05	0.000283	CcSEcCtD
Lisinopril—Shock—Capecitabine—kidney cancer	7.17e-05	0.000283	CcSEcCtD
Lisinopril—Urinary tract infection—Doxorubicin—kidney cancer	7.16e-05	0.000283	CcSEcCtD
Lisinopril—Thrombocytopenia—Capecitabine—kidney cancer	7.14e-05	0.000282	CcSEcCtD
Lisinopril—Tachycardia—Capecitabine—kidney cancer	7.11e-05	0.000281	CcSEcCtD
Lisinopril—Vomiting—Vincristine—kidney cancer	7.11e-05	0.000281	CcSEcCtD
Lisinopril—Skin disorder—Capecitabine—kidney cancer	7.08e-05	0.000279	CcSEcCtD
Lisinopril—Sweating—Doxorubicin—kidney cancer	7.06e-05	0.000279	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.06e-05	0.00143	CbGpPWpGaD
Lisinopril—Urticaria—Paclitaxel—kidney cancer	7.06e-05	0.000279	CcSEcCtD
Lisinopril—Rash—Vincristine—kidney cancer	7.05e-05	0.000278	CcSEcCtD
Lisinopril—Hyperhidrosis—Capecitabine—kidney cancer	7.05e-05	0.000278	CcSEcCtD
Lisinopril—Dermatitis—Vincristine—kidney cancer	7.04e-05	0.000278	CcSEcCtD
Lisinopril—Haematuria—Doxorubicin—kidney cancer	7.02e-05	0.000277	CcSEcCtD
Lisinopril—Body temperature increased—Paclitaxel—kidney cancer	7.02e-05	0.000277	CcSEcCtD
Lisinopril—Abdominal pain—Paclitaxel—kidney cancer	7.02e-05	0.000277	CcSEcCtD
Lisinopril—Headache—Vincristine—kidney cancer	7.01e-05	0.000277	CcSEcCtD
Lisinopril—Hepatobiliary disease—Doxorubicin—kidney cancer	6.97e-05	0.000275	CcSEcCtD
Lisinopril—Epistaxis—Doxorubicin—kidney cancer	6.95e-05	0.000274	CcSEcCtD
Lisinopril—Anorexia—Capecitabine—kidney cancer	6.95e-05	0.000274	CcSEcCtD
Lisinopril—Sinusitis—Doxorubicin—kidney cancer	6.91e-05	0.000273	CcSEcCtD
Lisinopril—Agranulocytosis—Doxorubicin—kidney cancer	6.87e-05	0.000271	CcSEcCtD
Lisinopril—Hypotension—Capecitabine—kidney cancer	6.81e-05	0.000269	CcSEcCtD
Lisinopril—Vomiting—Gemcitabine—kidney cancer	6.74e-05	0.000266	CcSEcCtD
Lisinopril—Bradycardia—Doxorubicin—kidney cancer	6.73e-05	0.000266	CcSEcCtD
Lisinopril—Rash—Gemcitabine—kidney cancer	6.69e-05	0.000264	CcSEcCtD
Lisinopril—Dermatitis—Gemcitabine—kidney cancer	6.68e-05	0.000264	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	6.65e-05	0.00135	CbGpPWpGaD
Lisinopril—Headache—Gemcitabine—kidney cancer	6.65e-05	0.000262	CcSEcCtD
Lisinopril—Nausea—Vincristine—kidney cancer	6.64e-05	0.000262	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Capecitabine—kidney cancer	6.64e-05	0.000262	CcSEcCtD
Lisinopril—Rhinitis—Doxorubicin—kidney cancer	6.63e-05	0.000262	CcSEcCtD
Lisinopril—Hepatitis—Doxorubicin—kidney cancer	6.61e-05	0.000261	CcSEcCtD
Lisinopril—Insomnia—Capecitabine—kidney cancer	6.59e-05	0.00026	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—kidney cancer	6.56e-05	0.000259	CcSEcCtD
Lisinopril—Paraesthesia—Capecitabine—kidney cancer	6.54e-05	0.000258	CcSEcCtD
Lisinopril—Hypersensitivity—Paclitaxel—kidney cancer	6.54e-05	0.000258	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—kidney cancer	6.53e-05	0.000258	CcSEcCtD
Lisinopril—Oedema peripheral—Doxorubicin—kidney cancer	6.51e-05	0.000257	CcSEcCtD
Lisinopril—Dyspnoea—Capecitabine—kidney cancer	6.5e-05	0.000257	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—kidney cancer	6.48e-05	0.000256	CcSEcCtD
Lisinopril—Dyspepsia—Capecitabine—kidney cancer	6.42e-05	0.000253	CcSEcCtD
Lisinopril—Asthenia—Paclitaxel—kidney cancer	6.37e-05	0.000252	CcSEcCtD
Lisinopril—Decreased appetite—Capecitabine—kidney cancer	6.34e-05	0.00025	CcSEcCtD
Lisinopril—Nausea—Gemcitabine—kidney cancer	6.3e-05	0.000249	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Capecitabine—kidney cancer	6.29e-05	0.000248	CcSEcCtD
Lisinopril—Fatigue—Capecitabine—kidney cancer	6.28e-05	0.000248	CcSEcCtD
Lisinopril—Pruritus—Paclitaxel—kidney cancer	6.28e-05	0.000248	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—kidney cancer	6.25e-05	0.000247	CcSEcCtD
Lisinopril—Pain—Capecitabine—kidney cancer	6.23e-05	0.000246	CcSEcCtD
Lisinopril—Constipation—Capecitabine—kidney cancer	6.23e-05	0.000246	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—kidney cancer	6.17e-05	0.000243	CcSEcCtD
Lisinopril—Flushing—Doxorubicin—kidney cancer	6.14e-05	0.000242	CcSEcCtD
Lisinopril—Diarrhoea—Paclitaxel—kidney cancer	6.08e-05	0.00024	CcSEcCtD
Lisinopril—Feeling abnormal—Capecitabine—kidney cancer	6.01e-05	0.000237	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—POMC—kidney cancer	6e-05	0.00122	CbGpPWpGaD
Lisinopril—Angiopathy—Doxorubicin—kidney cancer	6e-05	0.000237	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	5.97e-05	0.00121	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	5.97e-05	0.00121	CbGpPWpGaD
Lisinopril—Gastrointestinal pain—Capecitabine—kidney cancer	5.96e-05	0.000235	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—kidney cancer	5.96e-05	0.000235	CcSEcCtD
Lisinopril—Chills—Doxorubicin—kidney cancer	5.93e-05	0.000234	CcSEcCtD
Lisinopril—Arrhythmia—Doxorubicin—kidney cancer	5.91e-05	0.000233	CcSEcCtD
Lisinopril—Dizziness—Paclitaxel—kidney cancer	5.87e-05	0.000232	CcSEcCtD
Lisinopril—Alopecia—Doxorubicin—kidney cancer	5.84e-05	0.000231	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—kidney cancer	5.79e-05	0.000229	CcSEcCtD
Lisinopril—Urticaria—Capecitabine—kidney cancer	5.79e-05	0.000229	CcSEcCtD
Lisinopril—Abdominal pain—Capecitabine—kidney cancer	5.76e-05	0.000227	CcSEcCtD
Lisinopril—Body temperature increased—Capecitabine—kidney cancer	5.76e-05	0.000227	CcSEcCtD
Lisinopril—Malnutrition—Doxorubicin—kidney cancer	5.76e-05	0.000227	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—kidney cancer	5.76e-05	0.000227	CcSEcCtD
Lisinopril—Flatulence—Doxorubicin—kidney cancer	5.67e-05	0.000224	CcSEcCtD
Lisinopril—Tension—Doxorubicin—kidney cancer	5.65e-05	0.000223	CcSEcCtD
Lisinopril—Vomiting—Paclitaxel—kidney cancer	5.65e-05	0.000223	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—kidney cancer	5.64e-05	0.000223	CcSEcCtD
Lisinopril—Rash—Paclitaxel—kidney cancer	5.6e-05	0.000221	CcSEcCtD
Lisinopril—Dermatitis—Paclitaxel—kidney cancer	5.59e-05	0.000221	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	5.59e-05	0.00113	CbGpPWpGaD
Lisinopril—Nervousness—Doxorubicin—kidney cancer	5.59e-05	0.000221	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	5.58e-05	0.00113	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.58e-05	0.00113	CbGpPWpGaD
Lisinopril—Back pain—Doxorubicin—kidney cancer	5.57e-05	0.00022	CcSEcCtD
Lisinopril—Headache—Paclitaxel—kidney cancer	5.56e-05	0.00022	CcSEcCtD
Lisinopril—Muscle spasms—Doxorubicin—kidney cancer	5.53e-05	0.000218	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	5.48e-05	0.00111	CbGpPWpGaD
Lisinopril—Vision blurred—Doxorubicin—kidney cancer	5.43e-05	0.000214	CcSEcCtD
Lisinopril—Hypersensitivity—Capecitabine—kidney cancer	5.37e-05	0.000212	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—kidney cancer	5.34e-05	0.000211	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—kidney cancer	5.32e-05	0.00021	CcSEcCtD
Lisinopril—Nausea—Paclitaxel—kidney cancer	5.28e-05	0.000208	CcSEcCtD
Lisinopril—Asthenia—Capecitabine—kidney cancer	5.23e-05	0.000206	CcSEcCtD
Lisinopril—Malaise—Doxorubicin—kidney cancer	5.19e-05	0.000205	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—kidney cancer	5.17e-05	0.000204	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—kidney cancer	5.16e-05	0.000204	CcSEcCtD
Lisinopril—Pruritus—Capecitabine—kidney cancer	5.16e-05	0.000204	CcSEcCtD
Lisinopril—Leukopenia—Doxorubicin—kidney cancer	5.15e-05	0.000203	CcSEcCtD
Lisinopril—Palpitations—Doxorubicin—kidney cancer	5.09e-05	0.000201	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—kidney cancer	5.06e-05	0.0002	CcSEcCtD
Lisinopril—Cough—Doxorubicin—kidney cancer	5.02e-05	0.000198	CcSEcCtD
Lisinopril—Diarrhoea—Capecitabine—kidney cancer	4.99e-05	0.000197	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	4.9e-05	0.000993	CbGpPWpGaD
Lisinopril—Chest pain—Doxorubicin—kidney cancer	4.9e-05	0.000193	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—kidney cancer	4.9e-05	0.000193	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—kidney cancer	4.9e-05	0.000193	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—kidney cancer	4.88e-05	0.000193	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL2—kidney cancer	4.88e-05	0.000989	CbGpPWpGaD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.87e-05	0.000192	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	4.86e-05	0.000985	CbGpPWpGaD
Lisinopril—Discomfort—Doxorubicin—kidney cancer	4.84e-05	0.000191	CcSEcCtD
Lisinopril—Dizziness—Capecitabine—kidney cancer	4.82e-05	0.00019	CcSEcCtD
Lisinopril—Dry mouth—Doxorubicin—kidney cancer	4.79e-05	0.000189	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	4.79e-05	0.00097	CbGpPWpGaD
Lisinopril—Confusional state—Doxorubicin—kidney cancer	4.74e-05	0.000187	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—kidney cancer	4.7e-05	0.000185	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—kidney cancer	4.7e-05	0.000185	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	4.69e-05	0.00095	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	4.69e-05	0.00095	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	4.69e-05	0.00095	CbGpPWpGaD
Lisinopril—Infection—Doxorubicin—kidney cancer	4.67e-05	0.000184	CcSEcCtD
Lisinopril—Vomiting—Capecitabine—kidney cancer	4.63e-05	0.000183	CcSEcCtD
Lisinopril—Shock—Doxorubicin—kidney cancer	4.62e-05	0.000182	CcSEcCtD
Lisinopril—Thrombocytopenia—Doxorubicin—kidney cancer	4.6e-05	0.000182	CcSEcCtD
Lisinopril—Rash—Capecitabine—kidney cancer	4.6e-05	0.000181	CcSEcCtD
Lisinopril—Dermatitis—Capecitabine—kidney cancer	4.59e-05	0.000181	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—kidney cancer	4.59e-05	0.000181	CcSEcCtD
Lisinopril—Headache—Capecitabine—kidney cancer	4.57e-05	0.00018	CcSEcCtD
Lisinopril—Skin disorder—Doxorubicin—kidney cancer	4.56e-05	0.00018	CcSEcCtD
Lisinopril—Hyperhidrosis—Doxorubicin—kidney cancer	4.54e-05	0.000179	CcSEcCtD
Lisinopril—Anorexia—Doxorubicin—kidney cancer	4.48e-05	0.000177	CcSEcCtD
Lisinopril—Hypotension—Doxorubicin—kidney cancer	4.39e-05	0.000173	CcSEcCtD
Lisinopril—Nausea—Capecitabine—kidney cancer	4.33e-05	0.000171	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—CTNNB1—kidney cancer	4.28e-05	0.000868	CbGpPWpGaD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.28e-05	0.000169	CcSEcCtD
Lisinopril—Insomnia—Doxorubicin—kidney cancer	4.25e-05	0.000168	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—kidney cancer	4.22e-05	0.000167	CcSEcCtD
Lisinopril—Dyspnoea—Doxorubicin—kidney cancer	4.19e-05	0.000165	CcSEcCtD
Lisinopril—ABCB1—Metabolism—ACY1—kidney cancer	4.18e-05	0.000847	CbGpPWpGaD
Lisinopril—Somnolence—Doxorubicin—kidney cancer	4.18e-05	0.000165	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—kidney cancer	4.15e-05	0.00084	CbGpPWpGaD
Lisinopril—Dyspepsia—Doxorubicin—kidney cancer	4.14e-05	0.000163	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—kidney cancer	4.08e-05	0.000161	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.06e-05	0.00016	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—kidney cancer	4.05e-05	0.00016	CcSEcCtD
Lisinopril—Constipation—Doxorubicin—kidney cancer	4.02e-05	0.000159	CcSEcCtD
Lisinopril—Pain—Doxorubicin—kidney cancer	4.02e-05	0.000159	CcSEcCtD
Lisinopril—Feeling abnormal—Doxorubicin—kidney cancer	3.87e-05	0.000153	CcSEcCtD
Lisinopril—Gastrointestinal pain—Doxorubicin—kidney cancer	3.84e-05	0.000152	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—kidney cancer	3.73e-05	0.000147	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—kidney cancer	3.71e-05	0.000147	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—kidney cancer	3.71e-05	0.000147	CcSEcCtD
Lisinopril—ABCB1—Metabolism—PDHB—kidney cancer	3.55e-05	0.00072	CbGpPWpGaD
Lisinopril—Hypersensitivity—Doxorubicin—kidney cancer	3.46e-05	0.000137	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.42e-05	0.000693	CbGpPWpGaD
Lisinopril—Asthenia—Doxorubicin—kidney cancer	3.37e-05	0.000133	CcSEcCtD
Lisinopril—ABCB1—Metabolism—CCBL1—kidney cancer	3.34e-05	0.000677	CbGpPWpGaD
Lisinopril—Pruritus—Doxorubicin—kidney cancer	3.32e-05	0.000131	CcSEcCtD
Lisinopril—Diarrhoea—Doxorubicin—kidney cancer	3.21e-05	0.000127	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.15e-05	0.000639	CbGpPWpGaD
Lisinopril—Dizziness—Doxorubicin—kidney cancer	3.11e-05	0.000123	CcSEcCtD
Lisinopril—Vomiting—Doxorubicin—kidney cancer	2.99e-05	0.000118	CcSEcCtD
Lisinopril—Rash—Doxorubicin—kidney cancer	2.96e-05	0.000117	CcSEcCtD
Lisinopril—Dermatitis—Doxorubicin—kidney cancer	2.96e-05	0.000117	CcSEcCtD
Lisinopril—Headache—Doxorubicin—kidney cancer	2.94e-05	0.000116	CcSEcCtD
Lisinopril—ABCB1—Metabolism—GLIPR1—kidney cancer	2.9e-05	0.000587	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPAT—kidney cancer	2.9e-05	0.000587	CbGpPWpGaD
Lisinopril—Nausea—Doxorubicin—kidney cancer	2.79e-05	0.00011	CcSEcCtD
Lisinopril—ABCB1—Metabolism—FH—kidney cancer	2.69e-05	0.000546	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APRT—kidney cancer	2.69e-05	0.000546	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.69e-05	0.000544	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.66e-05	0.000538	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.6e-05	0.000527	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPC3—kidney cancer	2.53e-05	0.000513	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.47e-05	0.000501	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CA2—kidney cancer	2.46e-05	0.000499	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.46e-05	0.000499	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALAD—kidney cancer	2.4e-05	0.000486	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.39e-05	0.000484	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.35e-05	0.000476	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ST3GAL2—kidney cancer	2.34e-05	0.000475	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.34e-05	0.000475	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.32e-05	0.000471	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALDH1A1—kidney cancer	2.29e-05	0.000464	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.27e-05	0.000459	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC5A3—kidney cancer	2.2e-05	0.000445	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PGK1—kidney cancer	2.2e-05	0.000445	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LDHB—kidney cancer	2.15e-05	0.000436	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.05e-05	0.000415	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.94e-05	0.000392	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.88e-05	0.000382	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CA9—kidney cancer	1.87e-05	0.000378	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.84e-05	0.000373	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.74e-05	0.000353	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.6e-05	0.000324	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CRABP1—kidney cancer	1.59e-05	0.000322	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.55e-05	0.000313	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ITPR2—kidney cancer	1.48e-05	0.000299	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTT1—kidney cancer	1.35e-05	0.000273	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACHE—kidney cancer	1.35e-05	0.000273	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SCARB1—kidney cancer	1.27e-05	0.000258	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS1—kidney cancer	1.26e-05	0.000256	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PSMD7—kidney cancer	1.24e-05	0.000251	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—BCHE—kidney cancer	1.17e-05	0.000238	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC5A5—kidney cancer	1.16e-05	0.000235	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A1—kidney cancer	1.12e-05	0.000227	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.07e-05	0.000216	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTP1—kidney cancer	9.33e-06	0.000189	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTM1—kidney cancer	8.57e-06	0.000174	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP1A1—kidney cancer	8.12e-06	0.000165	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—POMC—kidney cancer	6.06e-06	0.000123	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—kidney cancer	4.83e-06	9.79e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTEN—kidney cancer	4.21e-06	8.54e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CA—kidney cancer	2.97e-06	6.02e-05	CbGpPWpGaD
